![]() |
市场调查报告书
商品编码
1452931
全球创伤固定装置市场 2024-2031Global Trauma Fixation Devices Market 2024-2031 |
预计在预测期内(2024-2031 年),全球创伤固定装置市场将以 7.4% 的CAGR成长。创伤固定器材市场的重要因素包括退化性骨疾病的增加、创伤固定器材研发投入的增加以及创伤和事故病例的增加。根据英国政府提供的全国统计数据,2022年,共有29,742人死亡或重伤(KSI),登记死亡病例1,711例,各种严重程度的伤亡135,480人。因此,英国的外科手术数量正在增加。
全球创伤固定装置市场按产品类型、材料、应用和最终用户细分。根据产品类型,市场分为内固定器和外固定器。内固定器包括板和螺丝、桿和销、电线和电缆、髓内钉和空心螺丝。外固定器包括单侧和双侧固定器、圆形固定器和混合固定器。根据材料,市场细分为不銹钢、钛和生物可吸收材料。根据应用,市场分为上肢、下肢、脊椎和其他(肋骨固定)。此外,根据最终用户,市场细分为医院、门诊手术中心和创伤中心。在这些材料中,生物可吸收材料子细分市场预计将占据相当大的市场份额,因为生物可吸收材料在创伤装置中的采用越来越多,可在体内降解,消除了切除手术的需要并改善了骨科治疗的效果。
其中,生物可吸收材料细分市场预计将在全球创伤固定器材市场中占据相当大的份额。该细分市场的成长归因于切除手术需求的减少以及生物材料技术和监管部门批准的不断进步。 2023 年 3 月,Bioretec Ltd. 的 RemeOs™ 创伤螺丝获得 FDA 市场授权,这是一种用于骨折癒合的生物可吸收镁合金植入物。它的目的是取代传统的钛和钢植入物,消除切除手术的需要,并提高手术效果。 RemeOs(TM) 支持骨科诊所的营运目标,并改善踝关节骨折患者的价值主张。
全球创伤固定器材市场根据地理位置进一步细分,包括北美(美国和加拿大)、欧洲(英国、义大利、西班牙、德国、法国和欧洲其他地区)、亚太地区(印度、中国、日本、韩国和亚洲其他地区)以及世界其他地区(中东和非洲以及拉丁美洲)。其中,欧洲预计将在全球市场中占据显着份额。其中一个重要因素,包括运动相关伤害的激增,增加了创伤固定解决方案的需求。根据美国国立卫生研究院(NIH) 2023 年题为「2021/22 欧洲橄榄球伤害监测报告:超级杯、20 岁以下和18 岁以下锦标赛」的研究,学校和18 岁以下运动员报告每1000 名球员中受伤率低于47 人- 比赛时间约为成年男子国际比赛的一半。
在所有地区中,北美地区预计在预测期内将以相当大的CAGR成长。该区域市场的成长归因于骨科手术发生率的上升、工业化的不断发展导致包括工作场所伤害在内的意外伤害发生率的上升,以及骨折和骨科创伤等外伤的发生率不断上升。根据美国劳工统计局的数据,2022年美国有5,486起致命工伤,比2021年的5,190起增加了5.7%。致命工伤率为每10万名全职当量工人中有3.7人死亡,到2021 年,每10 万名全职员工中的3.6 名将增加。由于这些因素,鼓励主要参与者推出该产品来满足当前的市场需求。 2023 年 9 月,Orthofix Medical 在美国推出了 Galaxy Fixation Gemini 系统。用于治疗下肢和上肢创伤性骨折的稳定外固定係统。
服务于全球创伤固定设备市场的主要公司包括 CONMED Corp.、DePuy Synthes(Johnson & Johnson 公司)、Integra LifeSciences Holdings Corp.、Smith & Nephew Plc 等。市场参与者透过各种策略(包括併购、合作、合作、融资和新产品发布),为市场成长做出了巨大贡献,以保持市场竞争力。例如,2024 年 1 月,Extremity Medical LLC 与全球医疗保健解决方案公司 Henry Schein, Inc. 合作,扩大其骨科四肢植入系统。此次合作旨在提高全球医疗保健成果。
Global Trauma Fixation Devices Market Size, Share & Trends Analysis Report by Product Type (Internal Fixators and External Fixators), by Material (Stainless Steel, Titanium, and Bioabsorbable Materials), by Applications (Upper Extremities, Lower Extremities, Spine, and Others), and by End-User (Hospitals, Ambulatory Surgical Centers (ASCs), and Trauma Centers) Forecast Period (2024-2031)
The global trauma fixation devices market is anticipated to grow at a CAGR of 7.4% during the forecast period (2024-2031). Significant factors contributing to the trauma fixation devices market include the rising of degenerative bone disorders, increasing investment in R&D of the trauma fixation devices, and increasing number of trauma and accident cases. According to the national statistics provided by the UK government, in 2022, 29,742 people were killed or seriously injured (KSI) casualties, 1,711 fatality cases were registered and 135,480 were casualties of all severities. As a result, the number of surgical procedures is increasing in the UK.
The global trauma fixation devices market is segmented by product type, material, application, and end-user. Based on the product types, the market is sub-segmented into internal fixators and external fixators. Internal fixators include plates and screws, rods and pins, wires and cables, intramedullary nails, and cannulated screws. External fixators include unilateral and bilateral fixators, circular fixators, and hybrid fixators. Based on the materials, the market is sub-segmented into stainless steel, titanium, and bioabsorbable materials. Based on the applications, the market is sub-segmented into upper extremities, lower extremities, spine, and others (rib fixation). Further, based on the end-user, the market is sub-segmented into hospitals, ambulatory surgical centers, and trauma centers. Among the materials, the bioabsorbable material sub-segment is projected to hold a significant share of the market, owing to the rising adoption of bioabsorbable materials in trauma devices degrade in the body, eliminating the need for removal surgeries and improving outcomes in orthopedic treatment.
Among the materials, the bioabsorbable materials sub-segment is expected to hold a considerable share of the global trauma fixation devices market. The segmental growth is attributed to the reduced need for removal surgery, and continuous advancements in biomaterials technology, regulatory approvals. In March 2023, Bioretec Ltd. received FDA market authorization for its RemeOs(TM) trauma screw, a bioresorbable magnesium alloy implant for bone fracture healing. It aimed to replace traditional titanium and steel implants, eliminating the need for removal surgery, and enhancing surgical outcomes. RemeOs(TM) supports operational goals for orthopedic clinics and improves the value proposition for patients with ankle fractures.
The global trauma fixation devices market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Europe is anticipated to hold a prominent share of the market across the globe. One of the significant factors, including a surge in sports-related injuries, boosted the demand for trauma fixation solutions. According to the 2023 National Institutes of Health (NIH) study titled "2021/22 Rugby Europe Injury Surveillance Report: SuperCup, Under-20, and Under-18 Championship," school and under-18 athletes reported injury rates below 47 per 1000 player-match-hours, about half of those in senior adult male international competitions.
Among all regions, the North American region is anticipated to grow at a considerable CAGR over the forecast period. The regional market growth is attributed to the rising incidence of orthopedic surgeries, the increasing industrialization leading to a heightened incidence of unintentional injuries including workplace injuries, and the increasing prevalence of traumatic injuries such as fractures and orthopedic trauma. According to the US Bureau of Labor Statistics, there were 5,486 fatal work injuries recorded in the US in 2022, marking a 5.7% increase from the 5,190 recorded in 2021. The fatal work injury rate was 3.7 fatalities per 100,000 full-time equivalent workers, up from 3.6 per 100,000 full-time equivalents in 2021. Owing to such factors, major key players are encouraged to introduce the product to address the prevailing market demand. In September 2023, Orthofix Medical launched its Galaxy Fixation Gemini system in the US. A stable external fixation system for treating trauma-induced fractures in the lower and upper limbs.
The major companies serving the global trauma fixation devices market include CONMED Corp., DePuy Synthes (a Johnson & Johnson company), Integra LifeSciences Holdings Corp., Smith & Nephew Plc, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in January 2024, Extremity Medical LLC partnered with Henry Schein, Inc., a global healthcare solutions company, expanding its orthopedic extremity implant systems. The collaboration aimed to enhance healthcare outcomes globally.